Evaluating the impact of immunization with the “pan-fungal” vaccine, NXT-2, on the gut mycobiome and microbiome in non-human primates (NHPs)
Microbiol Spectr. July 2026
Intramuscular administration of influenza hemagglutinin in one hind leg elicits similar protective immune responses as administration in two hind legs
Virology. May 2026
Infants under 24 months with severe malaria have a serological profile of active infection with Epstein Barr Virus
J Infect Dis. May 2026
Vaccine elicitation of HIV broadly neutralizing antibodies from genome-edited B cells in non-human primates and derived lymphoid organoids
Gene Ther. April 2026
Cage-Side Blood Collections from the Ear Can Be Used for Hematological Evaluations in Japanese Macaques (Macaca fuscata)
J Am Assoc Lab Anim Sci. March 2026
Receptor-binding specificity and antigenic properties of a genotype D1.1 A (H5N1) influenza virus isolated from a human
Emerg Microbes Infect. March 2026
Assessment of immunogenicity and protection induced by COBRA HA vaccines formulated with Infectimune in young and elderly ferrets
PLoS One. February 2026
PD-L1 is an intrinsic switch for natural killer cell-mediated, TRAIL-dependent antiviral function
Cell Rep. January 2026
Elicitation of Protective Immune Responses Against Influenza Virus Following Intranasal Delivery of Fluzone or Flublok Vaccines
Vaccines (Basel). January 2026
Protective efficacy of a ‘pan-fungal’ vaccination strategy against experimental Pneumocystis infection in drug-immunosuppressed macaques
Front Immunol. January 2026
Delineation of the antibody light chain biases and kinetics following primary and secondary influenza virus infections of ferrets
Immunohorizons. January 2026
Influenza hemagglutinin and neuraminidase multivalent vaccine elicits broader protective immune responses compared to vaccine formulations composed of hemagglutinin and neuraminidase
Hum Vaccin Immunother. December 2025
Elicitation of neutralizing antibodies and IgG4 subclass switching following booster vaccination with ancestral COVID-19 mRNA vaccines does not reduce breakthrough infections
Hum Vaccin Immunother. December 2025
Assessing factors associated with one-year antibody waning in participants with repeated influenza vaccinations: A six-year cohort study
Vaccine. December 2025
N-glycosylation at the receptor binding site drives differences in receptor binding specificity between influenza B virus lineages
J Virol. November 2025
Gene discovery and expression analysis of the B cell receptor repertoire in the domestic ferret model
Vaccine. October 2025
Active and Passive Immunization of Pan-Fungal Vaccine NXT-2 Reduces Morbidity and Mortality in an Immunosuppressed Murine Model of Candida auris Systemic Infection
Vaccines (Basel). October 2025
Elicitation of protective immune responses against influenza a viruses in elderly ferrets by adjuvanted recombinant universal influenza hemagglutinin vaccines
Immun Ageing. October 2025
Predicting influenza vaccine-elicited antibody responses with practical point systems
Vaccine. October 2025
Pharmacokinetic Analysis of Sustained-Release Buprenorphine Formulations in Owl Monkeys (Aotus spp.)
J Am Assoc Lab Anim Sci. September 2025
A Drug Repurposing Approach Reveals Targetable Epigenetic Pathways in Plasmodium vivax Hypnozoites
eLife. September 2025
Experimental Pneumocystis infection in dexamethasone immunosuppressed macaques
Med Mycol. September 2025
Non-neutralizing antibodies to influenza A matrix-protein-2-ectodomain are broadly effective therapeutics and resistant to viral escape mutations
Sci Adv. September 2025
Use of the Slow-Delivery Platform, VacSIM, Shapes the Host Immune Response to Increase Protection Against Influenza Infection
Viruses. August 2025
Controlling bird flu is urgent–for dairy, wildlife, poultry, pets, and people
J Am Vet Med Assoc. June 2025
Protective efficacy of the pan-fungal vaccine NXT-2 against vulvovaginal candidiasis in a murine model
NPJ Vaccines. June 2025
Leveraging pre-vaccination antibody titres across multiple influenza H3N2 variants to forecast the post-vaccination response.
EBioMedicine. June 2025
HaloPROTAC3 does not trigger the degradation of the halotagged parasitophorous vacuole membrane protein UIS4 during Plasmodium liver stage development
Sci Rep. May 2025
Multivalent H3 COBRA-based influenza vaccine elicits enhanced immune response in a pre-immune elderly ferret model
Vaccine. May 2025
COVID-19 Vaccination Enhances the Immunogenicity of Seasonal Influenza Vaccination in the Elderly
Vaccines (Basel). May 2025
Receptor-binding specificity of a bovine influenza A virus
Nature. April 2025
Neuraminidase-specific antibodies drive differential cross-protection between contemporary FLUBV lineages
Sci Adv. March 2025
A parainfluenza virus 5 (PIV5)-vectored intranasal SARS-CoV-2 vaccine (CVXGA1) elicits protective and long-lasting immunity in nonhuman primates
J Virol. March 2025
Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variants
J Virol. March 2025
A single dose of inactivated influenza virus vaccine expressing COBRA hemagglutinin elicits broadly-reactive and long-lasting protection
PLoS One. February 2025
Pandemic risk stemming from the bovine H5N1 outbreak: an account of the knowns and unknowns
J Virol. February 2025
Meeting Report From “Correlates of Protection for Next Generation Influenza Vaccines: Lessons Learned From the Covid-19 Pandemic”
Influenza Other Respir Viruses. October 2024
A recombinant N2 neuraminidase-based CpG 1018® adjuvanted vaccine provides protection against challenge with heterologous influenza viruses in mice and hamsters
Vaccine. October 2024
A kalihinol analog disrupts apicoplast function and vesicular trafficking in P. falciparum malaria
Science. September 2024
Influenza B Virus Receptor Specificity: Closing the Gap between Binding and Tropism
Viruses. August 2024
Establishment of Swine Primary Nasal, Tracheal, and Bronchial Epithelial Cell Culture Models for the Study of Influenza Virus Infection
J Virol Methods. June 2024
Pandemic Risk Assessment for Swine Influenza A Virus in Comparative In Vitro and In Vivo Models
Viruses. March 2024
Swine influenza A virus isolates containing the pandemic H1N1 origin matrix gene elicit greater disease in the murine model
Microbiol Spectr. March 2024
A general computational design strategy for stabilizing viral class I fusion proteins
Nat Commun. February 2024
Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses
Cell Rep. July 2023
Malaria disrupts the rhesus macaque gut microbiome
Front Cell Infect Microbiol. January 2023
A therapeutic vaccine strategy to prevent Pneumocystis pneumonia in an immunocompromised host in a non-human primate model of HIV and Pneumocystis co-infection
Front. Immunol. December 2022
Immunogenicity and protective efficacy of a pan-fungal vaccine in preclinical models of aspergillosis, candidiasis, and pneumocystosis
PNAS Nexus. November 2022
Mortality Trends in Risk Conditions and Invasive Mycotic Disease in the United States, 1999-2018
Clin Infect Dis. January 2022
Prevalence and Healthcare Burden of Fungal Infections in the United States, 2018
Open Forum Infect Dis. January 2022
Vaccine-Induced Protection in Two Murine Models of Invasive Pulmonary Aspergillosis
Front. Immunol. May 2021
